“Rivaroxaban Versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients With Non-Valvular Atrial Fibrillation”. 2020. University Heart Journal 16 (2): 99-105. https://doi.org/10.3329/uhj.v16i2.49666.